159 related articles for article (PubMed ID: 12832119)
1. Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa.
Thomas LD; Kyd JM; Bastin DA; Dunkley ML; Cripps AW
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):155-60. PubMed ID: 12832119
[TBL] [Abstract][Full Text] [Related]
2. Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection.
Thomas LD; Cripps AW; Kyd JM
Vaccine; 2009 May; 27(25-26):3324-30. PubMed ID: 19200832
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
4. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
5. Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung.
Thomas LD; Dunkley ML; Moore R; Reynolds S; Bastin DA; Kyd JM; Cripps AW
Vaccine; 2000 Sep; 19(2-3):348-57. PubMed ID: 10930690
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat.
Dunkley ML; Rajyaguru S; McCue A; Cripps AW; Kyd JM
FEMS Immunol Med Microbiol; 2003 Oct; 39(1):37-44. PubMed ID: 14556994
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
Front Immunol; 2019; 10():2497. PubMed ID: 31708925
[No Abstract] [Full Text] [Related]
8. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
Front Immunol; 2018; 9():1737. PubMed ID: 30093906
[No Abstract] [Full Text] [Related]
9. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
[TBL] [Abstract][Full Text] [Related]
10. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
11. The protective role of pulmonary neutrophils in rats intestinally immunized with Pseudomonas aeruginosa.
Buret A; Dunkley M; Clancy RL; Cripps AW
Adv Exp Med Biol; 1995; 371B():765-9. PubMed ID: 7502894
[No Abstract] [Full Text] [Related]
12. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model.
Gilleland HE; Gilleland LB; Matthews-Greer JM
Infect Immun; 1988 May; 56(5):1017-22. PubMed ID: 2833440
[TBL] [Abstract][Full Text] [Related]
13. Preservation of pulmonary function by an outer membrane protein F vaccine. A study in rats with chronic pulmonary infection caused by Pseudomonas aeruginosa.
Fox CW; Campbell GD; Anderson WM; Zavecz JH; Gilleland LB; Gilleland HE
Chest; 1994 May; 105(5):1545-50. PubMed ID: 8181349
[TBL] [Abstract][Full Text] [Related]
14. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
[TBL] [Abstract][Full Text] [Related]
15. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R; Sharma A; Wu W; Sung B; Worgall S
Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
[TBL] [Abstract][Full Text] [Related]
16. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
Johansen HK; Cryz SJ; Høiby N
APMIS; 1994 Jul; 102(7):545-53. PubMed ID: 7917224
[TBL] [Abstract][Full Text] [Related]
17. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
Döring G; Dorner F
Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to Pseudomonas aeruginosa surface protein antigens in a rat model of chronic lung infection.
Cochrane DM; Brown MR; Anwar H; Weller PH; Lam K; Costerton JW
J Med Microbiol; 1988 Dec; 27(4):255-61. PubMed ID: 3143837
[TBL] [Abstract][Full Text] [Related]
19. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
20. Conjugation of alginate to a synthetic peptide containing T- and B-cell epitopes as an induction for protective immunity against Pseudomonas aeruginosa.
Farjaha A; Owlia P; Siadat SD; Mousavi SF; Shafieeardestani M
J Biotechnol; 2014 Dec; 192 Pt A():240-7. PubMed ID: 25449544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
